ACTUATE THERAPEUTICS, INC. (ACTU) Insider Trading

Name: ACTUATE THERAPEUTICS, INC. (ACTU) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 14, 2026): Daniel M. Schmitt (President, CEO and Director): Exercise/Conversion of 272,056 shares.

Get alerted when insiders trade ACTU

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta